To the Editor In a recent issue of JAMA Internal Medicine, Dr Kesselheim and colleagues1 reported national survey results of physicians’ perceptions of generic drugs and how they learned about newly available generic drugs. While their data show increasing physician confidence in the safety and efficacy of generic drugs, they also found that generic skepticism is still common (32% of participants) and physicians do not know when generic drugs they commonly prescribe become available (50% of participants answered “sometimes,” “rarely,” or “never”). We agree with the authors that limiting interactions with pharmaceutical marketing and directed educational outreach about generic drugs are both needed.
Chee M, Ngooi S, Arora VM. Prescription Trends—Brand-name Drugs vs Generic. JAMA Intern Med. 2016;176(10):1573-1574. doi:10.1001/jamainternmed.2016.5375